A R T I C L E S
Paquette and Geng
Scheme 2
Scheme 3
a
Conditions: (a) Br2, CH2Cl2, 0 °C, 40 min; Et3N, 20 °C, 3 h (77%).
b) Ethylene glycol, Dowex 50X4-400, C6H6, reflux 3 days (80% br sm).
c) tert-Butyllithium, THF, -78 °C. (brsm ) based on recovered starting
(
(
material)
obtained via a 10-step sequence involving a combination of
chlorination, reduction, dehydration, and oxidation maneuvers
in the proper sequence. This degree of conciseness serves as
the basis for a formal total synthesis of coriolin (9) as well.1
An entirely different strategy has opened up a seven-step route
5,16
1
7,18
to the fungal metabolite ceratopicanol (10).
The latter
sequence is noteworthy in that three of the synthetic manipula-
tions involve the use of lithium in liquid ammonia for ac-
complishing different synthetic objectives.
Results and Discussion
(
()-Hypnophilin and (()-Coriolin. Central to the quest for
conrotatory opening of the cyclobutene ring with generation of
hypnophilin (8) is the seminal recognition by Steglich and co-
workers of its antitumor activity and ability to inhibit Gram-
positive and Gram-negative bacteria as well as diverse fungi
and yeasts. In addition, this linearly fused triquinane embodies
in its A ring an uncommon Michael acceptor arrangement that
is presumably responsible for its biological activity. These
considerations have prompted three successful syntheses of 8.
While the Little group made recourse to a 1,3-diyl trapping
the coiled 1,3,5,7-octatetraene 3. These intermediates are capable
6
4,5b
of rapid helical equilibration and regioselective cyclization
and have the ability to advance to product with asymmetric
13
7
induction. Arrival at 4 is realized somewhat more directly via
a dianionic oxy-Cope rearrangement when cis addition as in 2
8
operates. These mechanistic options can be distinguished when
9
additional stereochemical markers are present. The proper
positioning of an acetal group as in 4 allows for the operation
of an elimination reaction with the formation of 5. This step
guarantees that the subsequent transannular aldol ring closure
is completely regiodirected and that a highly functionalized
linear triquinane will be generated.10
1
4a
reaction as their key step, Curran deployed a tandem radical
cyclization, and Weinges completed an enantioselective route
by suitable structural modification of catalpol.
14b
1
4c
In 1969, the Umezawa group reported the isolation of coriolin
1
5
In this report, we detail for the first time the manner in which
select end products of these deep-seated cascade processes can
(9) and defined its structure. The more highly oxygenated
perimeter of this tricyclopentanoid system and its reputed
antitumor activity was sufficient cause for many investigators
to undertake its total synthesis. Since a key intermediate in
the routes devised by the Danishefsky, Ikegami, and Tatsuta
groups intersects our own abbreviated scheme, the present
undertaking also constitutes a stereocontrolled formal synthesis
of coriolin (9).
1
1
be utilized for the expeditious synthesis of natural products.
1
6
These goals demand that the signature part structure 7, invariably
generated from diisopropyl squarate, be amenable to reductive,
oxygenative, and alkylative modification (Scheme 2). Little
information is currently available concerning the chemical
17
18a
18b
1
2
alteration of this highly oxygenated cyclopentenone system.
Considerable progress has now been made to offset this
deficiency. Thus, the sesquiterpene hypnophilin (8)13,14 has been
Retrosynthetically, we envisioned the lithiated acetal 11 to
be a properly delineated reactant. This building block was
conveniently generated by bromination-dehydrobromination of
the known 5,5-dimethyl-2-cyclopentenone, standard acetal-
ization, and halogen-metal exchange in the presence of tert-
butyllithium, as outlined in Scheme 3.
(
(
(
7) Paquette, L. A.; Tae, J. J. Org. Chem. 1998, 63, 2022.
1
9
8) Paquette, L. A.; Morwick, T. M. J. Am. Chem. Soc. 1997, 119, 1230.
9) (a) Paquette, L. A.; Kuo, L. H.; Hamme, A. T., II; Kreuzholz, R.; Doyon,
J. J. Org. Chem. 1997, 62, 1730. (b) Paquette, L. A.; Kuo, L. H.; Doyon,
J. Tetrahedron 1996, 52, 11625. (c) Paquette, L. A.; Kuo, L. H.; Doyon,
J. J. Am. Chem. Soc. 1997, 119, 3038. (d) Paquette, L. A.; Kuo, L. H.;
Tae, J. J. Org. Chem. 1998, 63, 2010.
(
10) (a) Paquette, L. A.; Doyon, J. J. Am. Chem. Soc. 1995, 117, 6799. (b)
Paquette, L. A.; Doyon, J. J. Org. Chem. 1997, 62, 1723.
11) Preliminary communication of a portion of this investigation: Geng, F.;
Liu, J.; Paquette, L. A. Org. Lett. 2002, 4, 71.
(15) Isolation: (a) Takeuchi, T.; Iinuma, H.; Iwanaga, J.; Takahashi, S.; Takita,
T.; Umezawa, H. J. Antibiot. 1969, 22, 215. (b) Takahashi, S.; Naganawa,
H.; Iinuma, H.; Takita, T.; Maeda, K.; Umezawa, H. Tetrahedron Lett.
1971, 1955. (c) Nakamura, H.; Takita, T.; Umezawa, H.; Kunishita, M.;
Nakayama, Y.; Iitaka, Y. J. Antibiot. 1974, 27, 301.
(16) Synthesis: (a) Reference 14a. (b) Reference 14b. (c) Weinges, K.; Braun,
R.; Huber-Patz, U.; Irngartinger, H. Liebigs Ann. Chem. 1993, 1133. (d)
For a more extensive compilation, see footnote 5 of ref 14a.
(
(
12) Morwick, T. M.; Paquette, L. A. J. Org. Chem. 1996, 61, 146.
13) Isolation: (a) Kupka, J.; Anke, T.; Giannetti, B. M.; Steglich, W. Arch.
Microbiol. 1981, 130, 223. (b) Giannetti, B. M.; Steffan, B.; Steglich, W.;
Kupka, J.; Anke, T. Tetrahedron 1986, 42, 3587. (c) Steglich, W. Pure
Appl. Chem. 1981, 53, 1233.
14) Prior synthetic studies: (a) Van Hijfte, L.; Little, R. D.; Petersen, J. L.;
Moeller, K. D. J. Org. Chem. 1987, 52, 4647. (b) Fevig, T. L.; Elliott, R.
L.; Curran, D. P. J. Am. Chem. Soc. 1988, 110, 5064. (c) Weinges, K.;
Iatridou, H.; Dietz, U. Liebigs Ann. Chem. 1991, 893. (d) See also:
Weinges, K.; Dietz, U.; Oeser, T.; Irngartinger, H. Anew. Chem., Int. Ed.
Engl. 1990, 29, 680.
(
(17) (a) Danishefsky, S.; Zamboni, R.; Kahn, M.; Etheredge, S. J. J. Am. Chem.
Soc. 1980, 102, 2097. (b) Danishefsky, S.; Zamboni, R.; Kahn, M.;
Etheredge, S. J. J. Am. Chem. Soc. 1981, 103, 3460.
(
(18) (a) Iseki, K.; Yamazaki, M.; Shibasaki, M.; Ikegami, S. Tetrahedron 1981,
37, 4411. (b) Tatsuta, K.; Akimoto, K.; Kinoshita, M. J. Antibiot. 1980,
33, 100.
(19) Padwa, A.; Curtis, E. A.; Sandanayaka, V. P. J. Org. Chem. 1996, 61, 73.
9200 J. AM. CHEM. SOC.
9
VOL. 124, NO. 31, 2002